1	2	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Mutations	_	_	NNS	_	_	_	_	_
2	Induced	_	_	VBN	_	_	_	_	_
3	along	_	_	IN	_	_	_	_	_
4	with	_	_	IN	_	_	_	_	_
5	Genomic	_	_	JJ	_	_	_	_	_
6	Destabilization	_	_	NN	_	_	_	_	_


1	2.1	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Mutation	_	_	NN	_	_	_	_	_
2	Rate	_	_	NN	_	_	_	_	_
3	and	_	_	CC	_	_	_	_	_
4	Its	_	_	PRP$	_	_	_	_	_


1	Association	_	_	NN	_	_	_	_	_
2	with	_	_	IN	_	_	_	_	_
3	Cancer	_	_	NNP	_	_	_	_	_
4	Risk	_	_	NNP	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	normal	_	_	JJ	_	_	_	_	_
3	human	_	_	JJ	_	_	_	_	_
4	cells	_	_	NNS	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	DNA	_	_	NNP	_	_	_	_	_
7	is	_	_	VBZ	_	_	_	_	_
8	usually	_	_	RB	_	_	_	_	_
9	replicated	_	_	VBN	_	_	_	_	_
10	by	_	_	IN	_	_	_	_	_
11	high-fidelity	_	_	NN	_	_	_	_	_
12	polymerases	_	_	NNS	_	_	_	_	_
13	δ	_	_	NN	_	_	_	_	_
14	and	_	_	CC	_	_	_	_	_
15	ε	_	_	NN	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	Errors	_	_	NNS	_	_	_	_	_
2	caused	_	_	VBN	_	_	_	_	_
3	by	_	_	IN	_	_	_	_	_
4	those	_	_	DT	_	_	_	_	_
5	polymerases	_	_	NNS	_	_	_	_	_
6	are	_	_	VBP	_	_	_	_	_
7	primarily	_	_	RB	_	_	_	_	_
8	repaired	_	_	VBN	_	_	_	_	_
9	by	_	_	IN	_	_	_	_	_
10	their	_	_	PRP$	_	_	_	_	_
11	proofreading	_	_	NN	_	_	_	_	_
12	system	_	_	NN	_	_	_	_	_
13	(	_	_	-LRB-	_	_	_	_	_
14	Table	_	_	NN	_	_	_	_	_
15	1	_	_	CD	_	_	_	_	_
16	)	_	_	-RRB-	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	remaining	_	_	VBG	_	_	_	_	_
21	errors	_	_	NNS	_	_	_	_	_
22	are	_	_	VBP	_	_	_	_	_
23	targeted	_	_	VBN	_	_	_	_	_
24	by	_	_	IN	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	mismatch	_	_	NN	_	_	_	_	_
27	repair	_	_	NN	_	_	_	_	_
28	(	_	_	-LRB-	_	_	_	_	_
29	MMR	_	_	NNP	_	_	_	_	_
30	)	_	_	-RRB-	_	_	_	_	_
31	system	_	_	NN	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_


1	Consequently	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	mutation	_	_	NN	_	_	_	_	_
4	is	_	_	VBZ	_	_	_	_	_
5	largely	_	_	RB	_	_	_	_	_
6	suppressed	_	_	VBN	_	_	_	_	_
7	during	_	_	IN	_	_	_	_	_
8	normal	_	_	JJ	_	_	_	_	_
9	replication	_	_	NN	_	_	_	_	_
10	.	_	_	.	_	_	_	_	_


1	Deficiencies	_	_	NNS	_	_	_	_	_
2	in	_	_	IN	_	_	_	_	_
3	MMR	_	_	NNP	_	_	_	_	_
4	and	_	_	CC	_	_	_	_	_
5	proofreading	_	_	NN	_	_	_	_	_
6	performed	_	_	VBN	_	_	_	_	_
7	by	_	_	IN	_	_	_	_	_
8	polymerase	_	_	NN	_	_	_	_	_
9	ε	_	_	NN	_	_	_	_	_
10	are	_	_	VBP	_	_	_	_	_
11	associated	_	_	VBN	_	_	_	_	_
12	with	_	_	IN	_	_	_	_	_
13	hypermutation	_	_	NN	_	_	_	_	_
14	and	_	_	CC	_	_	_	_	_
15	cancer	_	_	NN	_	_	_	_	_
16	predisposition	_	_	NN	_	_	_	_	_
17	;	_	_	:	_	_	_	_	_
18	thus	_	_	RB	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	the	_	_	DT	_	_	_	_	_
21	mutation	_	_	NN	_	_	_	_	_
22	rate	_	_	NN	_	_	_	_	_
23	is	_	_	VBZ	_	_	_	_	_
24	strongly	_	_	RB	_	_	_	_	_
25	associated	_	_	VBN	_	_	_	_	_
26	with	_	_	IN	_	_	_	_	_
27	cancer	_	_	NN	_	_	_	_	_
28	risk	_	_	NN	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	this	_	_	DT	_	_	_	_	_
4	association	_	_	NN	_	_	_	_	_
5	between	_	_	IN	_	_	_	_	_
6	mutation	_	_	NN	_	_	_	_	_
7	rate	_	_	NN	_	_	_	_	_
8	and	_	_	CC	_	_	_	_	_
9	cancer	_	_	NN	_	_	_	_	_
10	risk	_	_	NN	_	_	_	_	_
11	may	_	_	MD	_	_	_	_	_
12	be	_	_	VB	_	_	_	_	_
13	unrelated	_	_	JJ	_	_	_	_	_
14	to	_	_	TO	_	_	_	_	_
15	cell	_	_	NN	_	_	_	_	_
16	division	_	_	NN	_	_	_	_	_
17	frequency	_	_	NN	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	resultant	_	_	JJ	_	_	_	_	_
20	changes	_	_	NNS	_	_	_	_	_
21	in	_	_	IN	_	_	_	_	_
22	cell	_	_	NN	_	_	_	_	_
23	number	_	_	NN	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	as	_	_	IN	_	_	_	_	_
26	aptly	_	_	RB	_	_	_	_	_
27	pointed	_	_	VBN	_	_	_	_	_
28	out	_	_	RP	_	_	_	_	_
29	by	_	_	IN	_	_	_	_	_
30	Peto	_	_	NNP	_	_	_	_	_
31	’s	_	_	POS	_	_	_	_	_
32	paradox	_	_	NN	_	_	_	_	_
33	:	_	_	:	_	_	_	_	_
34	cancer	_	_	NN	_	_	_	_	_
35	incidence	_	_	NN	_	_	_	_	_
36	does	_	_	VBZ	_	_	_	_	_
37	not	_	_	RB	_	_	_	_	_
38	appear	_	_	VB	_	_	_	_	_
39	to	_	_	TO	_	_	_	_	_
40	correlate	_	_	VB	_	_	_	_	_
41	with	_	_	IN	_	_	_	_	_
42	the	_	_	DT	_	_	_	_	_
43	number	_	_	NN	_	_	_	_	_
44	of	_	_	IN	_	_	_	_	_
45	cells	_	_	NNS	_	_	_	_	_
46	in	_	_	IN	_	_	_	_	_
47	an	_	_	DT	_	_	_	_	_
48	organism	_	_	NN	_	_	_	_	_
49	at	_	_	IN	_	_	_	_	_
50	the	_	_	DT	_	_	_	_	_
51	species	_	_	NN	_	_	_	_	_
52	level	_	_	NN	_	_	_	_	_
53	.	_	_	.	_	_	_	_	_


1	Mutations	_	_	NNS	_	_	_	_	_
2	in	_	_	IN	_	_	_	_	_
3	cancer	_	_	NN	_	_	_	_	_
4	cells	_	_	NNS	_	_	_	_	_
5	are	_	_	VBP	_	_	_	_	_
6	not	_	_	RB	_	_	_	_	_
7	induced	_	_	VBN	_	_	_	_	_
8	randomly	_	_	RB	_	_	_	_	_
9	.	_	_	.	_	_	_	_	_


1	Based	_	_	VBN	_	_	_	_	_
2	on	_	_	IN	_	_	_	_	_
3	whole-genome	_	_	JJ	_	_	_	_	_
4	and	_	_	CC	_	_	_	_	_
5	exome	_	_	NN	_	_	_	_	_
6	analyses	_	_	NNS	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	chromatin	_	_	NN	_	_	_	_	_
9	loci	_	_	NNS	_	_	_	_	_
10	with	_	_	IN	_	_	_	_	_
11	higher	_	_	JJR	_	_	_	_	_
12	mutation	_	_	NN	_	_	_	_	_
13	levels	_	_	NNS	_	_	_	_	_
14	can	_	_	MD	_	_	_	_	_
15	be	_	_	VB	_	_	_	_	_
16	characterized	_	_	VBN	_	_	_	_	_
17	as	_	_	IN	_	_	_	_	_
18	(	_	_	-LRB-	_	_	_	_	_
19	I	_	_	CD	_	_	_	_	_
20	)	_	_	-RRB-	_	_	_	_	_
21	gene	_	_	NN	_	_	_	_	_
22	loci	_	_	NNS	_	_	_	_	_
23	that	_	_	WDT	_	_	_	_	_
24	are	_	_	VBP	_	_	_	_	_
25	not	_	_	RB	_	_	_	_	_
26	highly	_	_	RB	_	_	_	_	_
27	expressed	_	_	VBN	_	_	_	_	_
28	,	_	_	,	_	_	_	_	_
29	(	_	_	-LRB-	_	_	_	_	_
30	II	_	_	NN	_	_	_	_	_
31	)	_	_	-RRB-	_	_	_	_	_
32	chromosome	_	_	NN	_	_	_	_	_
33	regions	_	_	NNS	_	_	_	_	_
34	replicating	_	_	VBG	_	_	_	_	_
35	in	_	_	IN	_	_	_	_	_
36	late	_	_	JJ	_	_	_	_	_
37	S	_	_	POS	_	_	_	_	_
38	phase	_	_	NN	_	_	_	_	_
39	,	_	_	,	_	_	_	_	_
40	(	_	_	-LRB-	_	_	_	_	_
41	III	_	_	NN	_	_	_	_	_
42	)	_	_	-RRB-	_	_	_	_	_
43	heterochromatic	_	_	JJ	_	_	_	_	_
44	loci	_	_	NNS	_	_	_	_	_
45	,	_	_	,	_	_	_	_	_
46	and	_	_	CC	_	_	_	_	_
47	(	_	_	-LRB-	_	_	_	_	_
48	IV	_	_	NN	_	_	_	_	_
49	)	_	_	-RRB-	_	_	_	_	_
50	loci	_	_	NNS	_	_	_	_	_
51	with	_	_	IN	_	_	_	_	_
52	closed	_	_	VBN	_	_	_	_	_
53	chromatin	_	_	NN	_	_	_	_	_
54	that	_	_	WDT	_	_	_	_	_
55	is	_	_	VBZ	_	_	_	_	_
56	not	_	_	RB	_	_	_	_	_
57	sensitive	_	_	JJ	_	_	_	_	_
58	to	_	_	TO	_	_	_	_	_
59	DNase	_	_	NN	_	_	_	_	_
60	I.	_	_	NN	_	_	_	_	_
61	Mutation	_	_	NN	_	_	_	_	_
62	rates	_	_	NNS	_	_	_	_	_
63	differ	_	_	VBP	_	_	_	_	_
64	by	_	_	IN	_	_	_	_	_
65	severalfold	_	_	NN	_	_	_	_	_
66	between	_	_	IN	_	_	_	_	_
67	high-	_	_	JJ	_	_	_	_	_
68	and	_	_	CC	_	_	_	_	_
69	low-mutation	_	_	JJ	_	_	_	_	_
70	loci	_	_	NNS	_	_	_	_	_
71	.	_	_	.	_	_	_	_	_


1	Although	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	source	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	these	_	_	DT	_	_	_	_	_
6	differences	_	_	NNS	_	_	_	_	_
7	remains	_	_	VBZ	_	_	_	_	_
8	unclear	_	_	JJ	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	phenomenon	_	_	NN	_	_	_	_	_
12	might	_	_	MD	_	_	_	_	_
13	be	_	_	VB	_	_	_	_	_
14	associated	_	_	VBN	_	_	_	_	_
15	with	_	_	IN	_	_	_	_	_
16	genomic	_	_	JJ	_	_	_	_	_
17	instability	_	_	NN	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	as	_	_	IN	_	_	_	_	_
20	heterochromatic	_	_	JJ	_	_	_	_	_
21	loci	_	_	NNS	_	_	_	_	_
22	are	_	_	VBP	_	_	_	_	_
23	often	_	_	RB	_	_	_	_	_
24	subjected	_	_	VBN	_	_	_	_	_
25	to	_	_	TO	_	_	_	_	_
26	replication	_	_	NN	_	_	_	_	_
27	stress	_	_	NN	_	_	_	_	_
28	and	_	_	CC	_	_	_	_	_
29	chromosomal	_	_	JJ	_	_	_	_	_
30	rearrangements	_	_	NNS	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	Consistent	_	_	JJ	_	_	_	_	_
2	with	_	_	IN	_	_	_	_	_
3	this	_	_	DT	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	recent	_	_	JJ	_	_	_	_	_
7	study	_	_	NN	_	_	_	_	_
8	reported	_	_	VBD	_	_	_	_	_
9	that	_	_	IN	_	_	_	_	_
10	hypermutation	_	_	NN	_	_	_	_	_
11	is	_	_	VBZ	_	_	_	_	_
12	associated	_	_	VBN	_	_	_	_	_
13	with	_	_	IN	_	_	_	_	_
14	genomic	_	_	JJ	_	_	_	_	_
15	destabilization	_	_	NN	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	2.2	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Mutation	_	_	NN	_	_	_	_	_
2	Induction	_	_	NN	_	_	_	_	_
3	when	_	_	WRB	_	_	_	_	_
4	Replication-Stress-Associated	_	_	JJ	_	_	_	_	_
5	DSBs	_	_	NNS	_	_	_	_	_
6	Accumulate	_	_	VBP	_	_	_	_	_


1	Among	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	many	_	_	JJ	_	_	_	_	_
4	mutations	_	_	NNS	_	_	_	_	_
5	induced	_	_	VBN	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	cancer	_	_	NN	_	_	_	_	_
8	cells	_	_	NNS	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	somatically-induced	_	_	JJ	_	_	_	_	_
11	replicative	_	_	JJ	_	_	_	_	_
12	mutations	_	_	NNS	_	_	_	_	_
13	are	_	_	VBP	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	most	_	_	RBS	_	_	_	_	_
16	prominent	_	_	JJ	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	Based	_	_	VBN	_	_	_	_	_
2	on	_	_	IN	_	_	_	_	_
3	a	_	_	DT	_	_	_	_	_
4	recent	_	_	JJ	_	_	_	_	_
5	study	_	_	NN	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	such	_	_	JJ	_	_	_	_	_
8	replicative	_	_	JJ	_	_	_	_	_
9	mutations	_	_	NNS	_	_	_	_	_
10	can	_	_	MD	_	_	_	_	_
11	be	_	_	VB	_	_	_	_	_
12	separated	_	_	VBN	_	_	_	_	_
13	into	_	_	IN	_	_	_	_	_
14	two	_	_	CD	_	_	_	_	_
15	types	_	_	NNS	_	_	_	_	_
16	:	_	_	:	_	_	_	_	_
17	those	_	_	DT	_	_	_	_	_
18	induced	_	_	VBN	_	_	_	_	_
19	as	_	_	IN	_	_	_	_	_
20	random	_	_	JJ	_	_	_	_	_
21	errors	_	_	NNS	_	_	_	_	_
22	during	_	_	IN	_	_	_	_	_
23	canonical	_	_	JJ	_	_	_	_	_
24	replication	_	_	NN	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	and	_	_	CC	_	_	_	_	_
27	those	_	_	DT	_	_	_	_	_
28	induced	_	_	VBN	_	_	_	_	_
29	in	_	_	IN	_	_	_	_	_
30	association	_	_	NN	_	_	_	_	_
31	with	_	_	IN	_	_	_	_	_
32	replication-stress-associated	_	_	JJ	_	_	_	_	_
33	DSBs	_	_	NNS	_	_	_	_	_
34	that	_	_	WDT	_	_	_	_	_
35	accumulate	_	_	VBP	_	_	_	_	_
36	in	_	_	IN	_	_	_	_	_
37	association	_	_	NN	_	_	_	_	_
38	with	_	_	IN	_	_	_	_	_
39	genomic	_	_	JJ	_	_	_	_	_
40	destabilization	_	_	NN	_	_	_	_	_
41	.	_	_	.	_	_	_	_	_


1	Unexpectedly	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	former	_	_	JJ	_	_	_	_	_
5	type	_	_	NN	_	_	_	_	_
6	is	_	_	VBZ	_	_	_	_	_
7	relatively	_	_	RB	_	_	_	_	_
8	rare	_	_	JJ	_	_	_	_	_
9	even	_	_	RB	_	_	_	_	_
10	in	_	_	IN	_	_	_	_	_
11	MMR-deficient	_	_	JJ	_	_	_	_	_
12	cells	_	_	NNS	_	_	_	_	_
13	that	_	_	WDT	_	_	_	_	_
14	cannot	_	_	MD	_	_	_	_	_
15	correct	_	_	VB	_	_	_	_	_
16	errors	_	_	NNS	_	_	_	_	_
17	during	_	_	IN	_	_	_	_	_
18	replication	_	_	NN	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	By	_	_	IN	_	_	_	_	_
2	contrast	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	in	_	_	IN	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	latter	_	_	JJ	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	hypermutation	_	_	NN	_	_	_	_	_
9	occurs	_	_	VBZ	_	_	_	_	_
10	in	_	_	IN	_	_	_	_	_
11	association	_	_	NN	_	_	_	_	_
12	with	_	_	IN	_	_	_	_	_
13	DSBs	_	_	NNS	_	_	_	_	_
14	and	_	_	CC	_	_	_	_	_
15	genomic	_	_	JJ	_	_	_	_	_
16	destabilization	_	_	NN	_	_	_	_	_
17	in	_	_	IN	_	_	_	_	_
18	barely	_	_	RB	_	_	_	_	_
19	replicating	_	_	VBG	_	_	_	_	_
20	cells	_	_	NNS	_	_	_	_	_
21	(	_	_	-LRB-	_	_	_	_	_
22	Figure	_	_	NN	_	_	_	_	_
23	1	_	_	CD	_	_	_	_	_
24	)	_	_	-RRB-	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	Importantly	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	cancer-driver	_	_	NN	_	_	_	_	_
4	mutations	_	_	NNS	_	_	_	_	_
5	arise	_	_	VBP	_	_	_	_	_
6	during	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	latter	_	_	NN	_	_	_	_	_
9	;	_	_	:	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	induced	_	_	VBN	_	_	_	_	_
12	mutations	_	_	NNS	_	_	_	_	_
13	include	_	_	VBP	_	_	_	_	_
14	base	_	_	NN	_	_	_	_	_
15	substitutions	_	_	NNS	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	small	_	_	JJ	_	_	_	_	_
18	insertions	_	_	NNS	_	_	_	_	_
19	and	_	_	CC	_	_	_	_	_
20	deletions	_	_	NNS	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	and	_	_	CC	_	_	_	_	_
23	large	_	_	JJ	_	_	_	_	_
24	deletions	_	_	NNS	_	_	_	_	_
25	of	_	_	IN	_	_	_	_	_
26	entire	_	_	JJ	_	_	_	_	_
27	genes	_	_	NNS	_	_	_	_	_
28	(	_	_	-LRB-	_	_	_	_	_
29	Figure	_	_	NN	_	_	_	_	_
30	1	_	_	CD	_	_	_	_	_
31	)	_	_	-RRB-	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	mechanisms	_	_	NNS	_	_	_	_	_
3	responsible	_	_	JJ	_	_	_	_	_
4	for	_	_	IN	_	_	_	_	_
5	mutations	_	_	NNS	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	this	_	_	DT	_	_	_	_	_
8	context	_	_	NN	_	_	_	_	_
9	are	_	_	VBP	_	_	_	_	_
10	not	_	_	RB	_	_	_	_	_
11	clear	_	_	JJ	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	probably	_	_	RB	_	_	_	_	_
14	because	_	_	IN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	presence	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	repair	_	_	NN	_	_	_	_	_
20	systems	_	_	NNS	_	_	_	_	_
21	and	_	_	CC	_	_	_	_	_
22	other	_	_	JJ	_	_	_	_	_
23	related	_	_	JJ	_	_	_	_	_
24	polymerases	_	_	NNS	_	_	_	_	_
25	(	_	_	-LRB-	_	_	_	_	_
26	Table	_	_	NN	_	_	_	_	_
27	1	_	_	CD	_	_	_	_	_
28	)	_	_	-RRB-	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	Indeed	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	these	_	_	DT	_	_	_	_	_
4	DSBs	_	_	NNS	_	_	_	_	_
5	are	_	_	VBP	_	_	_	_	_
6	generally	_	_	RB	_	_	_	_	_
7	a	_	_	DT	_	_	_	_	_
8	target	_	_	NN	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	homologous	_	_	JJ	_	_	_	_	_
11	recombination	_	_	NN	_	_	_	_	_
12	(	_	_	-LRB-	_	_	_	_	_
13	HR	_	_	NN	_	_	_	_	_
14	)	_	_	-RRB-	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	which	_	_	WDT	_	_	_	_	_
17	does	_	_	VBZ	_	_	_	_	_
18	not	_	_	RB	_	_	_	_	_
19	involve	_	_	VB	_	_	_	_	_
20	high-fidelity	_	_	JJ	_	_	_	_	_
21	polymerases	_	_	NNS	_	_	_	_	_
22	(	_	_	-LRB-	_	_	_	_	_
23	pols	_	_	NNS	_	_	_	_	_
24	)	_	_	-RRB-	_	_	_	_	_
25	δ	_	_	NN	_	_	_	_	_
26	and	_	_	CC	_	_	_	_	_
27	ε	_	_	NN	_	_	_	_	_
28	.	_	_	.	_	_	_	_	_


1	Instead	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	low-fidelity	_	_	JJ	_	_	_	_	_
4	translesion	_	_	NN	_	_	_	_	_
5	synthesis	_	_	NN	_	_	_	_	_
6	(	_	_	-LRB-	_	_	_	_	_
7	TLS	_	_	NN	_	_	_	_	_
8	)	_	_	-RRB-	_	_	_	_	_
9	polymerases	_	_	NNS	_	_	_	_	_
10	δ	_	_	FW	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	κ	_	_	NN	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	and	_	_	CC	_	_	_	_	_
15	θ	_	_	SYM	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	which	_	_	WDT	_	_	_	_	_
18	synthesize	_	_	VBP	_	_	_	_	_
19	DNA	_	_	NN	_	_	_	_	_
20	over	_	_	IN	_	_	_	_	_
21	lesioned	_	_	VBN	_	_	_	_	_
22	templates	_	_	NNS	_	_	_	_	_
23	,	_	_	,	_	_	_	_	_
24	are	_	_	VBP	_	_	_	_	_
25	highly	_	_	RB	_	_	_	_	_
26	expressed	_	_	VBN	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	Thus	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	higher	_	_	JJR	_	_	_	_	_
5	mutation	_	_	NN	_	_	_	_	_
6	rates	_	_	NNS	_	_	_	_	_
7	are	_	_	VBP	_	_	_	_	_
8	probably	_	_	RB	_	_	_	_	_
9	due	_	_	JJ	_	_	_	_	_
10	to	_	_	TO	_	_	_	_	_
11	DNA	_	_	NN	_	_	_	_	_
12	synthesis	_	_	NN	_	_	_	_	_
13	performed	_	_	VBN	_	_	_	_	_
14	by	_	_	IN	_	_	_	_	_
15	these	_	_	DT	_	_	_	_	_
16	polymerases	_	_	NNS	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	which	_	_	WDT	_	_	_	_	_
19	lack	_	_	VBP	_	_	_	_	_
20	proofreading	_	_	NN	_	_	_	_	_
21	activity	_	_	NN	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	and	_	_	CC	_	_	_	_	_
24	the	_	_	DT	_	_	_	_	_
25	errors	_	_	NNS	_	_	_	_	_
26	probably	_	_	RB	_	_	_	_	_
27	occur	_	_	VBP	_	_	_	_	_
28	during	_	_	IN	_	_	_	_	_
29	translesion	_	_	NN	_	_	_	_	_
30	synthesis	_	_	NN	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	Thus	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	while	_	_	IN	_	_	_	_	_
4	mutations	_	_	NNS	_	_	_	_	_
5	are	_	_	VBP	_	_	_	_	_
6	strongly	_	_	RB	_	_	_	_	_
7	suppressed	_	_	VBN	_	_	_	_	_
8	during	_	_	IN	_	_	_	_	_
9	normal	_	_	JJ	_	_	_	_	_
10	cell	_	_	NN	_	_	_	_	_
11	division	_	_	NN	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	they	_	_	PRP	_	_	_	_	_
14	increase	_	_	VBP	_	_	_	_	_
15	after	_	_	IN	_	_	_	_	_
16	replication-stress-associated	_	_	JJ	_	_	_	_	_
17	DSB	_	_	NN	_	_	_	_	_
18	accumulation	_	_	NN	_	_	_	_	_
19	and	_	_	CC	_	_	_	_	_
20	genomic	_	_	JJ	_	_	_	_	_
21	destabilization	_	_	NN	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	Given	_	_	VBN	_	_	_	_	_
2	that	_	_	IN	_	_	_	_	_
3	most	_	_	JJS	_	_	_	_	_
4	cancers	_	_	NNS	_	_	_	_	_
5	ultimately	_	_	RB	_	_	_	_	_
6	develop	_	_	VBP	_	_	_	_	_
7	genomic	_	_	JJ	_	_	_	_	_
8	instability	_	_	NN	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	these	_	_	DT	_	_	_	_	_
11	mutations	_	_	NNS	_	_	_	_	_
12	are	_	_	VBP	_	_	_	_	_
13	most	_	_	RBS	_	_	_	_	_
14	likely	_	_	JJ	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	ones	_	_	NNS	_	_	_	_	_
17	that	_	_	WDT	_	_	_	_	_
18	contribute	_	_	VBP	_	_	_	_	_
19	to	_	_	TO	_	_	_	_	_
20	cancer	_	_	NN	_	_	_	_	_
21	progression	_	_	NN	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	2.3	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Senescence-Associated	_	_	JJ	_	_	_	_	_
2	Increase	_	_	NN	_	_	_	_	_
3	in	_	_	IN	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	Risk	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	Genomic	_	_	JJ	_	_	_	_	_
8	Destabilization	_	_	NN	_	_	_	_	_


1	Most	_	_	JJS	_	_	_	_	_
2	cancer	_	_	NN	_	_	_	_	_
3	cells	_	_	NNS	_	_	_	_	_
4	develop	_	_	VBP	_	_	_	_	_
5	one	_	_	CD	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	two	_	_	CD	_	_	_	_	_
8	forms	_	_	NNS	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	genomic	_	_	JJ	_	_	_	_	_
11	instability	_	_	NN	_	_	_	_	_
12	:	_	_	:	_	_	_	_	_
13	chromosomal	_	_	JJ	_	_	_	_	_
14	instability	_	_	NN	_	_	_	_	_
15	(	_	_	-LRB-	_	_	_	_	_
16	CIN	_	_	NN	_	_	_	_	_
17	)	_	_	-RRB-	_	_	_	_	_
18	or	_	_	CC	_	_	_	_	_
19	microsatellite	_	_	JJ	_	_	_	_	_
20	instability	_	_	NN	_	_	_	_	_
21	(	_	_	-LRB-	_	_	_	_	_
22	MSI	_	_	NNP	_	_	_	_	_
23	)	_	_	-RRB-	_	_	_	_	_
24	.	_	_	.	_	_	_	_	_


1	CIN	_	_	NNP	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	most	_	_	RBS	_	_	_	_	_
5	frequent	_	_	JJ	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	but	_	_	CC	_	_	_	_	_
8	MSI	_	_	NNP	_	_	_	_	_
9	usually	_	_	RB	_	_	_	_	_
10	arises	_	_	VBZ	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	MMR-deficient	_	_	JJ	_	_	_	_	_
13	cancers	_	_	NNS	_	_	_	_	_
14	(	_	_	-LRB-	_	_	_	_	_
15	Table	_	_	NN	_	_	_	_	_
16	1	_	_	CD	_	_	_	_	_
17	)	_	_	-RRB-	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	induction	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	both	_	_	CC	_	_	_	_	_
5	CIN	_	_	NNP	_	_	_	_	_
6	and	_	_	CC	_	_	_	_	_
7	MSI	_	_	NNP	_	_	_	_	_
8	is	_	_	VBZ	_	_	_	_	_
9	triggered	_	_	VBN	_	_	_	_	_
10	by	_	_	IN	_	_	_	_	_
11	replication-stress-associated	_	_	JJ	_	_	_	_	_
12	DSBs	_	_	NNS	_	_	_	_	_
13	(	_	_	-LRB-	_	_	_	_	_
14	Figure	_	_	NN	_	_	_	_	_
15	2	_	_	CD	_	_	_	_	_
16	)	_	_	-RRB-	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	CIN	_	_	NNP	_	_	_	_	_
2	often	_	_	RB	_	_	_	_	_
3	occurs	_	_	VBZ	_	_	_	_	_
4	when	_	_	WRB	_	_	_	_	_
5	such	_	_	JJ	_	_	_	_	_
6	DSBs	_	_	NNS	_	_	_	_	_
7	are	_	_	VBP	_	_	_	_	_
8	not	_	_	RB	_	_	_	_	_
9	effectively	_	_	RB	_	_	_	_	_
10	repaired	_	_	VBN	_	_	_	_	_
11	by	_	_	IN	_	_	_	_	_
12	HR	_	_	NN	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	that	_	_	DT	_	_	_	_	_
15	is	_	_	VBZ	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	when	_	_	WRB	_	_	_	_	_
18	DSBs	_	_	NNP	_	_	_	_	_
19	arising	_	_	VBG	_	_	_	_	_
20	during	_	_	IN	_	_	_	_	_
21	replication	_	_	NN	_	_	_	_	_
22	are	_	_	VBP	_	_	_	_	_
23	carried	_	_	VBN	_	_	_	_	_
24	over	_	_	RP	_	_	_	_	_
25	into	_	_	IN	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	following	_	_	VBG	_	_	_	_	_
28	G1	_	_	NN	_	_	_	_	_
29	phase	_	_	NN	_	_	_	_	_
30	at	_	_	IN	_	_	_	_	_
31	a	_	_	DT	_	_	_	_	_
32	time	_	_	NN	_	_	_	_	_
33	when	_	_	WRB	_	_	_	_	_
34	HR	_	_	NN	_	_	_	_	_
35	is	_	_	VBZ	_	_	_	_	_
36	not	_	_	RB	_	_	_	_	_
37	functional	_	_	JJ	_	_	_	_	_
38	.	_	_	.	_	_	_	_	_


1	Consequently	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	DSBs	_	_	NNS	_	_	_	_	_
5	are	_	_	VBP	_	_	_	_	_
6	often	_	_	RB	_	_	_	_	_
7	erroneously	_	_	RB	_	_	_	_	_
8	ligated	_	_	VBN	_	_	_	_	_
9	by	_	_	IN	_	_	_	_	_
10	non-homologous	_	_	JJ	_	_	_	_	_
11	end	_	_	NN	_	_	_	_	_
12	joining	_	_	NN	_	_	_	_	_
13	(	_	_	-LRB-	_	_	_	_	_
14	NHEJ	_	_	NNP	_	_	_	_	_
15	)	_	_	-RRB-	_	_	_	_	_
16	with	_	_	IN	_	_	_	_	_
17	topologically	_	_	RB	_	_	_	_	_
18	incorrect	_	_	JJ	_	_	_	_	_
19	broken	_	_	VBN	_	_	_	_	_
20	ends	_	_	NNS	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	resulting	_	_	VBG	_	_	_	_	_
23	in	_	_	IN	_	_	_	_	_
24	a	_	_	DT	_	_	_	_	_
25	background	_	_	NN	_	_	_	_	_
26	that	_	_	WDT	_	_	_	_	_
27	causes	_	_	VBZ	_	_	_	_	_
28	CIN-associated	_	_	JJ	_	_	_	_	_
29	chromosomal	_	_	JJ	_	_	_	_	_
30	alterations	_	_	NNS	_	_	_	_	_
31	such	_	_	JJ	_	_	_	_	_
32	as	_	_	IN	_	_	_	_	_
33	chromosomal	_	_	JJ	_	_	_	_	_
34	translocations	_	_	NNS	_	_	_	_	_
35	,	_	_	,	_	_	_	_	_
36	deletions	_	_	NNS	_	_	_	_	_
37	,	_	_	,	_	_	_	_	_
38	and	_	_	CC	_	_	_	_	_
39	rearrangements	_	_	NNS	_	_	_	_	_
40	.	_	_	.	_	_	_	_	_


1	By	_	_	IN	_	_	_	_	_
2	contrast	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	MSI	_	_	NNP	_	_	_	_	_
5	arises	_	_	VBZ	_	_	_	_	_
6	when	_	_	WRB	_	_	_	_	_
7	those	_	_	DT	_	_	_	_	_
8	DSBs	_	_	NNS	_	_	_	_	_
9	are	_	_	VBP	_	_	_	_	_
10	effectively	_	_	RB	_	_	_	_	_
11	but	_	_	CC	_	_	_	_	_
12	erroneously	_	_	RB	_	_	_	_	_
13	repaired	_	_	VBN	_	_	_	_	_
14	by	_	_	IN	_	_	_	_	_
15	microhomology-mediated	_	_	JJ	_	_	_	_	_
16	end	_	_	NN	_	_	_	_	_
17	joining	_	_	NN	_	_	_	_	_
18	(	_	_	-LRB-	_	_	_	_	_
19	MMEJ	_	_	NN	_	_	_	_	_
20	;	_	_	:	_	_	_	_	_
21	also	_	_	RB	_	_	_	_	_
22	known	_	_	VBN	_	_	_	_	_
23	as	_	_	IN	_	_	_	_	_
24	alternative	_	_	JJ	_	_	_	_	_
25	end	_	_	NN	_	_	_	_	_
26	joining	_	_	NN	_	_	_	_	_
27	)	_	_	-RRB-	_	_	_	_	_
28	(	_	_	-LRB-	_	_	_	_	_
29	Figure	_	_	NN	_	_	_	_	_
30	3	_	_	CD	_	_	_	_	_
31	)	_	_	-RRB-	_	_	_	_	_
32	,	_	_	,	_	_	_	_	_
33	during	_	_	IN	_	_	_	_	_
34	which	_	_	WDT	_	_	_	_	_
35	CIN	_	_	NN	_	_	_	_	_
36	is	_	_	VBZ	_	_	_	_	_
37	suppressed	_	_	VBN	_	_	_	_	_
38	because	_	_	IN	_	_	_	_	_
39	of	_	_	IN	_	_	_	_	_
40	the	_	_	DT	_	_	_	_	_
41	resultant	_	_	JJ	_	_	_	_	_
42	DSB	_	_	NN	_	_	_	_	_
43	repair	_	_	NN	_	_	_	_	_
44	(	_	_	-LRB-	_	_	_	_	_
45	Figure	_	_	NN	_	_	_	_	_
46	2	_	_	CD	_	_	_	_	_
47	)	_	_	-RRB-	_	_	_	_	_
48	.	_	_	.	_	_	_	_	_


1	Thus	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	both	_	_	CC	_	_	_	_	_
4	CIN	_	_	NNP	_	_	_	_	_
5	and	_	_	CC	_	_	_	_	_
6	MSI	_	_	NNP	_	_	_	_	_
7	are	_	_	VBP	_	_	_	_	_
8	triggered	_	_	VBN	_	_	_	_	_
9	by	_	_	IN	_	_	_	_	_
10	replication-stress-associated	_	_	JJ	_	_	_	_	_
11	DSBs	_	_	NNS	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	arise	_	_	VB	_	_	_	_	_
14	due	_	_	JJ	_	_	_	_	_
15	to	_	_	TO	_	_	_	_	_
16	abnormalities	_	_	NNS	_	_	_	_	_
17	in	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	repair	_	_	NN	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	these	_	_	DT	_	_	_	_	_
22	lesions	_	_	NNS	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_


1	Most	_	_	JJS	_	_	_	_	_
2	cancers	_	_	NNS	_	_	_	_	_
3	develop	_	_	VBP	_	_	_	_	_
4	genomic	_	_	JJ	_	_	_	_	_
5	instability	_	_	NN	_	_	_	_	_
6	due	_	_	JJ	_	_	_	_	_
7	to	_	_	TO	_	_	_	_	_
8	abnormalities	_	_	NNS	_	_	_	_	_
9	in	_	_	IN	_	_	_	_	_
10	DSB	_	_	NNP	_	_	_	_	_
11	repair	_	_	NN	_	_	_	_	_
12	;	_	_	:	_	_	_	_	_
13	paradoxically	_	_	RB	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	however	_	_	RB	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	most	_	_	RBS	_	_	_	_	_
18	lack	_	_	VBP	_	_	_	_	_
19	background	_	_	NN	_	_	_	_	_
20	mutations	_	_	NNS	_	_	_	_	_
21	in	_	_	IN	_	_	_	_	_
22	DNA	_	_	NN	_	_	_	_	_
23	repair	_	_	NN	_	_	_	_	_
24	systems	_	_	NNS	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	raises	_	_	VBZ	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	question	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	how	_	_	WRB	_	_	_	_	_
7	genomic	_	_	JJ	_	_	_	_	_
8	destabilization	_	_	NN	_	_	_	_	_
9	occurs	_	_	VBZ	_	_	_	_	_
10	even	_	_	RB	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	normal	_	_	JJ	_	_	_	_	_
13	cells	_	_	NNS	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	that	_	_	WDT	_	_	_	_	_
16	is	_	_	VBZ	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	genetically	_	_	RB	_	_	_	_	_
19	normal	_	_	JJ	_	_	_	_	_
20	cells	_	_	NNS	_	_	_	_	_
21	with	_	_	IN	_	_	_	_	_
22	functional	_	_	JJ	_	_	_	_	_
23	DNA	_	_	NN	_	_	_	_	_
24	repair	_	_	NN	_	_	_	_	_
25	systems	_	_	NNS	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	phenomenon	_	_	NN	_	_	_	_	_
3	is	_	_	VBZ	_	_	_	_	_
4	probably	_	_	RB	_	_	_	_	_
5	associated	_	_	VBN	_	_	_	_	_
6	with	_	_	IN	_	_	_	_	_
7	age	_	_	NN	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	which	_	_	WDT	_	_	_	_	_
10	is	_	_	VBZ	_	_	_	_	_
11	associated	_	_	VBN	_	_	_	_	_
12	with	_	_	IN	_	_	_	_	_
13	an	_	_	DT	_	_	_	_	_
14	elevated	_	_	VBN	_	_	_	_	_
15	cancer	_	_	NN	_	_	_	_	_
16	risk	_	_	NN	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	Indeed	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	irreparable	_	_	JJ	_	_	_	_	_
4	DSBs	_	_	NNS	_	_	_	_	_
5	accumulate	_	_	VBP	_	_	_	_	_
6	widely	_	_	RB	_	_	_	_	_
7	in	_	_	IN	_	_	_	_	_
8	association	_	_	NN	_	_	_	_	_
9	with	_	_	IN	_	_	_	_	_
10	age	_	_	NN	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	vivo	_	_	NN	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	passage	_	_	NN	_	_	_	_	_
15	in	_	_	IN	_	_	_	_	_
16	vitro	_	_	FW	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	Consistent	_	_	JJ	_	_	_	_	_
2	with	_	_	IN	_	_	_	_	_
3	this	_	_	DT	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	cells	_	_	NNS	_	_	_	_	_
6	often	_	_	RB	_	_	_	_	_
7	undergo	_	_	VBP	_	_	_	_	_
8	senescence	_	_	NN	_	_	_	_	_
9	as	_	_	IN	_	_	_	_	_
10	a	_	_	DT	_	_	_	_	_
11	consequence	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	DSB	_	_	NN	_	_	_	_	_
14	accumulation	_	_	NN	_	_	_	_	_
15	.	_	_	.	_	_	_	_	_


1	Although	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	reasons	_	_	NNS	_	_	_	_	_
4	for	_	_	IN	_	_	_	_	_
5	DSB	_	_	NNP	_	_	_	_	_
6	accumulation	_	_	NN	_	_	_	_	_
7	are	_	_	VBP	_	_	_	_	_
8	not	_	_	RB	_	_	_	_	_
9	clear	_	_	JJ	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	they	_	_	PRP	_	_	_	_	_
12	are	_	_	VBP	_	_	_	_	_
13	likely	_	_	JJ	_	_	_	_	_
14	to	_	_	TO	_	_	_	_	_
15	include	_	_	VB	_	_	_	_	_
16	a	_	_	DT	_	_	_	_	_
17	reduction	_	_	NN	_	_	_	_	_
18	in	_	_	IN	_	_	_	_	_
19	histone	_	_	NN	_	_	_	_	_
20	H2AX	_	_	NNP	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	which	_	_	WDT	_	_	_	_	_
23	mediates	_	_	VBZ	_	_	_	_	_
24	repair-factor	_	_	NN	_	_	_	_	_
25	recruitment	_	_	NN	_	_	_	_	_
26	and	_	_	CC	_	_	_	_	_
27	is	_	_	VBZ	_	_	_	_	_
28	required	_	_	VBN	_	_	_	_	_
29	for	_	_	IN	_	_	_	_	_
30	genome	_	_	NN	_	_	_	_	_
31	stability	_	_	NN	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_

